Research and Development

Showing 15 posts of 9573 posts found.

2-in-1: Merck and Schering-Plough

April 8, 2009 Research and Development, Sales and Marketing Merck, Schering-Plough, merger, pharma

The Merck and Schering-Plough merger creates a new industry giant to challenge Pfizer in terms of its scale and annual …

Covance acquires early clinical development business in Switzerland

April 8, 2009 Research and Development Covance

Covance has expanded its presence in clinical pharmacology in Europe with the acquisition of Swiss Pharma Contract, a 50-bed clinical …

Top CROs can look forward to ‘five years of growth’

April 8, 2009 Research and Development CRO

The current economic downturn is having a braking effect on the top 10 contract research organisations, but a new report …

Quintiles completes 400th trial using electronic data capture

April 7, 2009 Research and Development CRO, Quintiles

Quintiles has completed its 400th clinical trial using Electronic Data Capture (EDC). In addition to starting its 400th EDC trial, …

MEP animal testing vote angers welfare groups

April 7, 2009 Research and Development, Sales and Marketing Animal testing, Europe, preclinical

The European Parliament's Agriculture and Rural Development Committee has been accused of watering down proposals drawn up by the European …

A new approach to CRO partnerships

April 6, 2009 Research and Development Pfizer, UK, clincal, partnerships

Contract research organisations now play an indispensable role in helping pharmaceutical companies develop their drugs. But as the number and …

Lilly forges risk-sharing R&D alliance with India’s Zydus

April 6, 2009 Research and Development Asia, India, lilly

Eli Lilly has forged a research collaboration with India's Zydus Cadila that sees the two companies combine their efforts in …

Consolidation wave expected in contract manufacturing

April 6, 2009 Research and Development CRO

The mergers and acquisitions that have become a feature of the contract research organisation (CRO) sector in recent years look …

Pfizer halts Sutent head-to-head trial

April 6, 2009 Research and Development, Sales and Marketing Cancer, Pfizer, Sutent

Pfizer has halted a late-stage breast cancer trial between Sutent and Roche's Xeloda, after the study failed to show significant …

Working Life: Maneesh Juneja

April 3, 2009 Research and Development GSK, productivity

How did you find your way into your current role? After graduating with a degree in business & computing, I …

Telehealth awareness reaches tipping point

April 2, 2009 Research and Development, Sales and Marketing digi, healthcare

Analysts Datamonitor believe that telehealth has reached the tipping point in terms of awareness, with IBM following Intel's entrance into …

Takeda chooses US base for its global development headquarters

April 2, 2009 Research and Development Takeda

Takeda Pharmaceutical Company is shifting its global development HQ from Japan to the US. The move will see that function …

CROs under pressure as early-stage pipelines dry up

March 27, 2009 Research and Development Pharmsource

There was a sharp slowdown in pharmaceutical outsourcing in the last six months which "really caught a lot of people …

GSK pledges further trial transparency

March 26, 2009 Research and Development, Sales and Marketing GSK

GlaxoSmithKline is to make its clinical trials more transparent through a series of moves it believes will facilitate clinical research. …

NICE recommends Pfizer’s Sutent

March 26, 2009 Research and Development NICE, Pfizer, Sutent

NICE has issued its final guidance on Pfizer's Sutent, recommending the kidney cancer drug as a first-line treatment. The drug …
The Gateway to Local Adoption Series

Latest content